In Silico Biosciences is an innovator in predictive, computer-based mechanistic models that support drug discovery for chronic pain and diseases of the central nervous system and development of clinical tools to address unmet needs of patients with chronic pain.

Today, after two decades of drug discovery support for the pharmaceutical industry, we are proud to build on our legacy by focusing our core strengths on pain drug discovery and on tools for clinician use in prescribing safe and effective precision therapies that make a difference for patients with chronic pain.

Inspired by patients who suffer from chronic pain and motivated by the dedicated clinicians who manage their care, our goal is to offer an expanded range of treatment options to produce improved patient outcomes and heightened patient satisfaction.